We are live on ! Find out more
PSTV icon

Plus Therapeutics
PSTV

3 hedge funds and large institutions have $33.4M invested in Plus Therapeutics in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $32.1M → $33.4M (+$1.28M)

0% more funds holding

Funds holding: 3 → 3 (0)

70% less call options, than puts

Call options by funds: $164K | Put options by funds: $542K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$164K
Puts
$542K
Net Calls
-$378K
Net Calls Change
+$208K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$143K
2
SIP
Stoneridge Investment Partners
Pennsylvania
-$134K
3
Principal Financial Group
Principal Financial Group
Iowa
-$59K
4
RCM
Rotella Capital Management
Washington
-$48K
5
PC
Passport Capital
California
-$42K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$185K – – –
UOC
27
UBS O'Connor
Illinois
$175K – – –
RAM
28
Redmond Asset Management
Virginia
$168K – – –
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$152K – – –
ProShare Advisors
30
ProShare Advisors
Maryland
$148K – – –
AllianceBernstein
31
AllianceBernstein
Tennessee
$125K – – –
AIG
32
American International Group
New York
$124K – – –
Wells Fargo
33
Wells Fargo
California
$120K – – –
Janney Montgomery Scott
34
Janney Montgomery Scott
Pennsylvania
$116K – – –
NFA
35
Nationwide Fund Advisors
Ohio
$116K – – –
State Board of Administration of Florida Retirement System
36
State Board of Administration of Florida Retirement System
Florida
$105K – – –
BA
37
BlackRock Advisors
Delaware
$96K – – –
DekaBank Deutsche Girozentrale
38
DekaBank Deutsche Girozentrale
Germany
$88K – – –
Group One Trading
39
Group One Trading
Illinois
$83K – – –
Commonwealth Equity Services
40
Commonwealth Equity Services
Massachusetts
$78K – – –
GC
41
Guggenheim Capital
Illinois
$71K – – –
AC
42
Amici Capital
New York
$70K – – –
CS
43
Credit Suisse
Switzerland
$64K – – –
DD
44
Dominick & Dominick
New York
$64K – – –
EEG
45
E.E. Geduld
$58K – – –
Citadel Advisors
46
Citadel Advisors
Florida
$56K – – –
Nomura Holdings
47
Nomura Holdings
Japan
$53K – – –
RFC
48
Russell Frank Company
Washington
$50K – – –
U
49
UBS
Switzerland
$49K – – –
LPL Financial
50
LPL Financial
California
$44K – – –
1
2
3 4

PSTV Hedge Fund Activity: Q3 2013 in Review

3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2013, worth a combined $33.4M — up 4% from $32.1M a quarter earlier.

Fund positioning in PSTV was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $143K.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $33.4M of Plus Therapeutics stock for Q3 2013, up 4% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q3 2013 and 0 closed out.
  • The largest Plus Therapeutics seller in Q3 2013 was Gilder Gagnon Howe & Co, an estimated $143K sold.

Based on aggregated 13F filings for Q3 2013.